Clearstead Advisors, LLC Insmed Inc Transaction History
Clearstead Advisors, LLC
- $6.44 Billion
- Q4 2024
A detailed history of Clearstead Advisors, LLC transactions in Insmed Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 418 shares of INSM stock, worth $31,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
418
Previous 475
12.0%
Holding current value
$31,304
Previous $34,000
17.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.07 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$971 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$951 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$533 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.1B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...